Clinical Trials

ClinicalTrials.gov registrations across deep tech.

Showing 24 of 19,428 clinical trials

Health Ahead: Sequential Comparative-Effectiveness Studies Toward Automated, Universally Deployable Preventive Health Screening

NCT07669168Started 3 months ago

NARECRUITINGINTERVENTIONAL

Sponsor: Sponsor not in directory

Source: ClinicalTrials.gov · Synced about 2 months ago

Six Versus Twelve Month SurveillAnce Following Resection of Nonpedunculated ColorectaL Polyps 20-50 mm IN Size Without High Grade Dysplasia (HGD)

NCT07198945Started 3 months ago

NAENROLLING_BY_INVITATIONINTERVENTIONAL

Sponsor: Indiana University

Source: ClinicalTrials.gov · Synced about 2 months ago

Ruxolitinib-Enhanced Conditioning for Pediatric and Young Adult Patients With Symptomatic Sickle Cell Disease Undergoing Haploidentical Hematopoietic Cell Transplantation

NCT07252050Started 3 months ago

PHASE1PHASE2RECRUITINGINTERVENTIONAL

Sponsor: Sponsor not in directory

Source: ClinicalTrials.gov · Synced about 2 months ago

A Randomized, Double-blinded, Placebo-controlled, Parallel Group, Phase 2a Study to Assess the Activity, Safety, and Tolerability of SAR445399 in Adult Participants With Non-Cystic Fibrosis Bronchiectasis (NCFB)

NCT07547436Started 3 months ago

PHASE2SUSPENDEDINTERVENTIONAL

Sponsor: Sanofi

Source: ClinicalTrials.gov · Synced 4 days ago

Breathing for Two: Inspiratory Muscle Strength Training for Supporting Healthy Blood Pressure in Pregnancy

NCT07687745Started 3 months ago

EARLY_PHASE1RECRUITINGINTERVENTIONAL

Sponsor: Sponsor not in directory

Source: ClinicalTrials.gov · Synced about 2 months ago

Development and Pilot Evaluation of a Novel Mobile Health Intervention for Young Adult Tobacco Cessation

NCT07571018Started 3 months ago

NARECRUITINGINTERVENTIONAL

Sponsor: Fred Hutchinson Cancer Center

Source: ClinicalTrials.gov · Synced about 2 months ago

A Phase 3, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of RAP-219 in Adult Participants With Focal Seizures

NCT07563881Started 3 months ago

PHASE3RECRUITINGINTERVENTIONAL

Sponsor: Rapport Therapeutics Inc.

Source: ClinicalTrials.gov · Synced 4 days ago

An Open-Label Extension Study to Evaluate the Long-Term Safety and Efficacy of BBP-418 (Ribitol) in Participants With Limb-Girdle Muscular Dystrophy 2I/R9 (LGMD2I/R9)

NCT07678775Started 3 months ago

PHASE3ACTIVE_NOT_RECRUITINGINTERVENTIONAL

Sponsor: Sponsor not in directory

Source: ClinicalTrials.gov · Synced about 2 months ago

A Phase 3 Randomized, Open-Label Study of Atebimetinib in Combination With the Modified Gemcitabine and Nab-Paclitaxel Regimen Versus the Standard Gemcitabine and Nab-Paclitaxel Regimen for the Treatment of Patients With Metastatic Pancreatic Ductal Pancreatic Adenocarcinoma Cancer (MAPKeeper 301)

NCT07562152Started 3 months ago

PHASE3RECRUITINGINTERVENTIONAL

Sponsor: Immuneering Corporation

Source: ClinicalTrials.gov · Synced 4 days ago

A Multi-Site Trial of Tirzepatide for Smoking Cessation

NCT07602699Started 3 months ago

PHASE2RECRUITINGINTERVENTIONAL

Sponsor: University of Southern California

Source: ClinicalTrials.gov · Synced about 2 months ago

A Phase 2, Open-Label, Single-Arm Study of Lirafugratinib in Patients With Previously Treated, Unresectable, Locally Advanced or Metastatic Solid Tumors (Excluding Cholangiocarcinoma) With FGFR2 Fusion or Rearrangement

NCT07359820Started 3 months ago

PHASE2RECRUITINGINTERVENTIONAL

Sponsor: Elevar Therapeutics

Source: ClinicalTrials.gov · Synced 4 days ago

A Phase 3, Randomized, Double-blind, Placebo-Controlled, Efficacy and Safety Study of HBS-301 in Participants With Narcolepsy Followed by an Open-label Extension

NCT07675135Started 3 months ago

PHASE3RECRUITINGINTERVENTIONAL

Sponsor: Harmony Biosciences Management, Inc.

Source: ClinicalTrials.gov · Synced 4 days ago

A Phase 3 Multicenter, Double-Masked, Randomized, Placebo-Controlled Study to Investigate the Safety, Tolerability, and Efficacy of Gildeuretinol Acetate (ALK 001) on the Progression of Stargardt Disease (STGD)

NCT07419334Started 3 months ago

PHASE3RECRUITINGINTERVENTIONAL

Sponsor: Alkeus Pharmaceuticals, Inc.

Source: ClinicalTrials.gov · Synced 4 days ago

Bumetanide vs. Furosemide for Adults Hospitalized With Cirrhosis: the BUFF Trial

NCT06941415Started 3 months ago

PHASE3RECRUITINGINTERVENTIONAL

Sponsor: Stacy Johnson

Source: ClinicalTrials.gov · Synced about 2 months ago

A Phase III, Randomized, Placebo-controlled, Parallel Group, Double-blind Study to Evaluate the Efficacy and Safety of NIO752 in Participants With Progressive Supranuclear Palsy Followed by an Open Label Extension

NCT07498426Started 3 months ago

PHASE3RECRUITINGINTERVENTIONAL

Sponsor: Novartis Pharmaceuticals

Source: ClinicalTrials.gov · Synced 4 days ago

Phentermine's Impact on Treatment in Teens (PhITT): A Randomized Placebo-Controlled Trial of Phentermine for Adolescents With Obesity

NCT07282340Started 3 months ago

PHASE2RECRUITINGINTERVENTIONAL

Sponsor: Russell McCulloh, MD

Source: ClinicalTrials.gov · Synced 4 days ago

A Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase II Study to Evaluate the Efficacy and Safety of D-2570 in Participants With Moderate to Severe Plaque Psoriasis

NCT07489885Started 3 months ago

PHASE2RECRUITINGINTERVENTIONAL

Sponsor: InventisBio Co., Ltd

Source: ClinicalTrials.gov · Synced about 2 months ago

Phase 3, Multicenter, Randomized, Double-Masked, Vehicle-Controlled, Parallel Group Study to Evaluate the Safety and Efficacy of Recombinant Human Nerve Growth Factor Eye Drop Solution in Participants With Persistent Corneal Epithelial Defect (PCED)

NCT07519902Started 3 months ago

PHASE3RECRUITINGINTERVENTIONAL

Sponsor: Sponsor not in directory

Source: ClinicalTrials.gov · Synced about 2 months ago

Evaluation of the Safety and Tolerability of Ixoberogene Soroparvovec (Ixo-vec) Intravitreal Gene Therapy in the Second (Contralateral) Eye of Participants With Bilateral Neovascular Age-related Macular Degeneration.

NCT07630649Started 3 months ago

PHASE2RECRUITINGINTERVENTIONAL

Sponsor: Adverum Biotechnologies, Inc.

Source: ClinicalTrials.gov · Synced 4 days ago

Testing the Impact of the My Own Health Report Intervention With 3 Distinct Options for Structured Follow-up as Compared to a Control Condition

NCT07569224Started 3 months ago

NARECRUITINGINTERVENTIONAL

Sponsor: Sponsor not in directory

Source: ClinicalTrials.gov · Synced about 2 months ago

A Phase 3, Single-arm, Open-label Extension Study to Evaluate the Safety of Finerenone in Addition to Standard of Care, in Pediatric Heart Failure Patients, From Birth to 18 Years of Age, With Left Ventricular Systolic Dysfunction (LVSD)

NCT07192952Started 3 months ago

PHASE3RECRUITINGINTERVENTIONAL

Sponsor: Sponsor not in directory

Source: ClinicalTrials.gov · Synced about 2 months ago

An Operationally Seamless Phase 2b/3, Multicenter, Randomized, Masked, Sham-controlled Study to Evaluate the Efficacy and Safety of Surabgene Lomparvovec (Sura-vec) Delivered Via Suprachoroidal Space (SCS) Injection Targeting Subjects With Diabetic Retinopathy Without Center Involved-Diabetic Macular Edema (CI-DME) (NAAVIGATE)

NCT07592273Started 3 months ago

PHASE2PHASE3RECRUITINGINTERVENTIONAL

Sponsor: AbbVie

Source: ClinicalTrials.gov · Synced 4 days ago

A First-in-human, Open-label, Dose Escalation and Expansion Study Evaluating the Safety, Tolerability, Pharmacokinetics, and Activity of 3HP-2827 in Patients With Unresectable or Metastatic Solid Tumors With FGFR2 Alterations

NCT06287918Started 3 months ago

PHASE1NOT_YET_RECRUITINGINTERVENTIONAL

Sponsor: 3H (Suzhou) Pharmaceuticals Co., Ltd.

Source: ClinicalTrials.gov · Synced about 2 months ago

Safety and Efficacy of Intracameral Zimoxin (0.1% Moxifloxacin Solution) for Prevention of Endophthalmitis After Cataract Surgery

NCT03244072Started 3 months ago

PHASE2PHASE3NOT_YET_RECRUITINGINTERVENTIONAL

Sponsor: Jason Ahee, M.D.

Source: ClinicalTrials.gov · Synced about 2 months ago

Load more (24)

Trial data sourced from ClinicalTrials.gov, a service of the U.S. National Library of Medicine.